David B. Miklos

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 35 papers. Top paper: “CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial”.

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Nature Medicine(2021)10.1038/s41591-021-01436-0

N/A

4.8DataRank · unranked

582 citations

Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird +44 more

Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and “antibodyome” measures

Proceedings of the National Academy of Sciences(2009)10.1073/pnas.0900563106

N/A

3.8DataRank · unranked

102 citations

Rong Chen, Neeraja Kambham, Maarten Naesens, Tara K. Sigdel, David B. Miklos +4 more

Protein microarrays identify antibodies to protein kinase Cζ that are associated with a greater risk of allograft loss in pediatric renal transplant recipients

Kidney International(2009)10.1038/ki.2009.384

N/A

2.1DataRank · unranked

60 citations

Li Li, Tara K. Sigdel, Persis P. Wadia, David B. Miklos, Atul Janardhan Butte +2 more

Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial

The Journal of Experimental Medicine(2020)10.1084/jem.20191712

N/A

1.5DataRank · unranked

39 citations

Michael S. Khodadoust, Debra K. Czerwinski, Ole Audun Werner Haabeth, Michael P. Chu, David B. Miklos +19 more

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

The Lancet(2024)10.1016/s0140-6736(24)00746-3

N/A

1.4DataRank · unranked

60 citations

John H. Baird, Anne Marijn Kramer, Hrishikesh K. Srinagesh, Shabnum Patel, Annie Kathleen Brown +43 more

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

New England Journal of Medicine(2017)10.1056/nejmoa1707447

N/A

1.3DataRank · unranked

5812 citations

Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson +41 more

A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.07.009

N/A

1.2DataRank · unranked

40 citations

Farnaz Fouladi, Fiona B. Tamburini, Bita Sahaf, Tkachenko Ei, Courtney Greene +11 more

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2020)10.1200/jco.19.02104

N/A

1.0DataRank · unranked

800 citations

Michael D. Jain, Lei Feng, Jay Y. Spiegel, Armin Ghobadi, Yi Lin +23 more

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023011625

N/A

0.906DataRank · unranked

31 citations

Anna Pavlova, Robert Lowsky, Lori Muffly, Parveen Shiraz, Sally Arai +17 more

Donor regulatory T-cell therapy to prevent graft-versus-host disease

Blood(2025)10.1182/blood.2024026446

N/A

0.900DataRank · unranked

39 citations

Anna Pavlova, Alejandro Villar‐Prados, Cameron S. Bader, Bryan J. Xie, Lori Muffly +23 more

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

Nature Medicine(2022)10.1038/s41591-022-01960-7

N/A

0.828DataRank · unranked

248 citations

Jay Y. Spiegel, Bita Sahaf, Meena Malipatlolla, Zachary Ehlinger, Sreevidya Kurra +25 more

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

Nature Medicine(2022)10.1038/s41591-022-01916-x

N/A

0.799DataRank · unranked

205 citations

Regis Perbost, Frederick L. Locke, Michael D. Jain, Sarah Turcan, Corinne Danan +17 more

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Blood Advances(2021)10.1182/bloodadvances.2020002732

N/A

0.792DataRank · unranked

196 citations

David J. Epstein, John Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig +18 more

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021004716

N/A

0.659DataRank · unranked

80 citations

Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder +16 more

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0.650DataRank · unranked

75 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more

Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7552

N/A

0.396DataRank · unranked

13 citations

Frederick L. Locke, Zhen‐Huan Hu, Tanya Siddiqi, Sairah Ahmed, Armin Ghobadi +15 more

Allogeneic Antibodies Identify GVL Targets CHAF1b and NuSAP1 in AML Patients.

Blood(2007)10.1182/blood.v110.11.168.168

N/A

0.372DataRank · unranked

3 citations

Atul Janardhan Butte, David B. Miklos, Marc Coram, Persis P. Wadia

Phase 2 study of MGTA-145 + plerixafor for rapid and reliable hematopoietic stem cell (HSC) mobilization for autologous transplant in multiple myeloma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8023

N/A

0.120DataRank · unranked

1 citations

Andriyana K. Bankova, Hitomi Hosoya, Lori Muffly, Shaji Kumar, Laura Johnston +14 more

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias

Research Square(2025)10.21203/rs.3.rs-7746241/v1

N/A

0.104DataRank · unranked

1 citations

Mark P. Hamilton, Nick Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio +32 more

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas

Blood Advances(2023)10.1182/bloodadvances.2023011997

N/A

0DataRank · unranked

5 citations

Joseph G. Schroers‐Martin, Brian J. Sworder, Karan R. Kathuria, Stefan Alig, Matthew J. Frank +8 more

Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma

Journal of Neuropathology & Experimental Neurology(2023)10.1093/jnen/nlac121

N/A

0DataRank · unranked

10 citations

Saman Ahmadian, Sushma Bharadwaj, Lehi Acosta-Alvarez, Zachary Threlkeld, Matthew J. Frank +5 more

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

New England Journal of Medicine(2024)10.1056/nejmoa2401361

N/A

0DataRank · unranked

190 citations

Takeshi Sugio, Troy Noordenbos, Shuyu Shi, Philip L. Bulterys, Chih Long Liu +12 more

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Blood Advances(2024)10.1182/bloodadvances.2024012637

N/A

0DataRank · unranked

24 citations

Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani +27 more

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008975

N/A

0DataRank · unranked

16 citations

Eric Lau, Mark Hamilton, Anmol Goyal, Hrishi Srinagesh, Alexandria Jensen +26 more

Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.02.025

N/A

0DataRank · unranked

3 citations

Bita Sahaf, Fang Wu, Zachary Ehlinger, Sally Arai, David B. Miklos +1 more

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy

American Journal of Hematology(2024)10.1002/ajh.27283

N/A

0DataRank · unranked

4 citations

Hailin Wang, Zhen‐Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson +18 more

341: Allogeneic Antibodies Specifically Target AML Antigen NuSAP1 after Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation(2008)10.1016/j.bbmt.2007.12.351

N/A

0DataRank · unranked

0 citations

Persis P. Wadia, Marc Coram, Atul Janardhan Butte, David B. Miklos

Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.04.016

N/A

0DataRank · unranked

23 citations

Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein, Victoria Osgood +12 more

Global Assessment of B Cell Alloimmunity Using Human Protein Microarrays

Clinical Immunology(2007)10.1016/j.clim.2007.03.371

N/A

0DataRank · unranked

0 citations

Marc Coram, Marina Sirota, David B. Miklos, Atul Janardhan Butte, Persis P. Wadia

Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.02.026

N/A

0DataRank · unranked

9 citations

Lori Muffly, Parveen Shiraz, Judith A. Shizuru, Laura Johnston, Sally Arai +9 more

Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.010

N/A

0DataRank · unranked

13 citations

Juliana Craig, Stefan Torelli, Kristen Cunanan, María Iglesias, Sally Arai +14 more

Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.01.010

N/A

0DataRank · unranked

18 citations

Joseph Caveney, Bin Yao, Teresa Lopes Ramos, Jan Bögeholz, Kartoosh Heydari +17 more

Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009426

N/A

0DataRank · unranked

29 citations

Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed Hossain, Michael D. Jain +5 more

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Blood Advances(2023)10.1182/bloodadvances.2023011489

N/A

0DataRank · unranked

26 citations

Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin +21 more

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

Bone Marrow Transplantation(2023)10.1038/s41409-023-02168-0

N/A

0DataRank · unranked

9 citations

Kristopher Attwood, Xiaojun Liu, George L. Chen, Hans Minderman, Amin M. Alousi +16 more